Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

US Patent 8586754 · Granted Nov 19, 2013

Estimated economic value: $67,258,000

Assignee

Inventors

View full patent text on Google Patents →